Yannick Debing

The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075

Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies

Hepatitis E virus replication and interferon responses in human placental cells

Update on hepatitis E virology: Implications for clinical practice

Viral Macro Domains Reverse Protein ADP-Ribosylation

Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity

Extra‐hepatic replication and infection of hepatitis E virus in neuronal‐derived cells

A rat model for hepatitis E virus

Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin

The future of antivirals

Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication

A Mutation in the Hepatitis E Virus RNA Polymerase Promotes Its Replication and Associates With Ribavirin Treatment Failure in Organ Transplant Recipients

Calcineurin Inhibitors Stimulate and Mycophenolic Acid Inhibits Replication of Hepatitis E Virus

Ribavirin Inhibits <i>In Vitro</i> Hepatitis E Virus Replication through Depletion of Cellular GTP Pools and Is Moderately Synergistic with Alpha Interferon

The Viral Polymerase Inhibitor 2′- <i>C</i> -Methylcytidine Inhibits Norwalk Virus Replication and Protects against Norovirus-Induced Diarrhea and Mortality in a Mouse Model

Intervention strategies for emerging viruses: use of antivirals